ECSP088907A - Vacuna en contra de organismos similares a rickettsia - Google Patents

Vacuna en contra de organismos similares a rickettsia

Info

Publication number
ECSP088907A
ECSP088907A EC2008008907A ECSP088907A ECSP088907A EC SP088907 A ECSP088907 A EC SP088907A EC 2008008907 A EC2008008907 A EC 2008008907A EC SP088907 A ECSP088907 A EC SP088907A EC SP088907 A ECSP088907 A EC SP088907A
Authority
EC
Ecuador
Prior art keywords
vaccine against
similar organisms
rickettsia
against rickettsia
similar
Prior art date
Application number
EC2008008907A
Other languages
English (en)
Inventor
Luc Grisez
Chow Yong Ng
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of ECSP088907A publication Critical patent/ECSP088907A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere al uso de bacterias del género Estreptococo para la fabricación de una vacuna para combatir la infección provocada por el organismo similar a Rickettsia.
EC2008008907A 2006-05-30 2008-11-21 Vacuna en contra de organismos similares a rickettsia ECSP088907A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80966006P 2006-05-30 2006-05-30
EP06114710 2006-05-30

Publications (1)

Publication Number Publication Date
ECSP088907A true ECSP088907A (es) 2008-12-30

Family

ID=38432974

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2008008907A ECSP088907A (es) 2006-05-30 2008-11-21 Vacuna en contra de organismos similares a rickettsia

Country Status (4)

Country Link
CR (1) CR10457A (es)
EC (1) ECSP088907A (es)
MX (1) MX2008015164A (es)
WO (1) WO2007138036A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200936759A (en) * 2007-12-21 2009-09-01 Intervet Int Bv Fish vaccine
TWI551295B (zh) 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
TWI449533B (zh) 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗
BR112012009309B1 (pt) * 2009-10-19 2021-10-05 Intervet International B.V Vacina combinada, uso de células de microrganismos,método para a preparação de uma vacina combinada, e, kit de partes
KR101976764B1 (ko) * 2017-12-19 2019-05-09 제주대학교 산학협력단 활주세균의 병원성 약독화 기술 및 활주세균병 예방을 위한 생약독화 백신 조성물
KR101992455B1 (ko) * 2018-09-11 2019-06-24 제주대학교 산학협력단 활주세균의 병원성 약독화 기술 및 활주세균병 예방을 위한 생약독화 백신 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6379677B1 (en) * 2000-02-25 2002-04-30 The United States Of America As Represented By The Secretary Of The Department Of Agriculture Streptococcus iniae vaccine

Also Published As

Publication number Publication date
CR10457A (es) 2009-02-26
WO2007138036A1 (en) 2007-12-06
MX2008015164A (es) 2008-12-12

Similar Documents

Publication Publication Date Title
ES2523968T3 (es) Terapia de combinación antibacteriana para el tratamiento de infecciones por bacterias Gram-positivas
CY1121175T1 (el) Καταστολη οργανισμων βιο-μεμβρανης
ECSP088907A (es) Vacuna en contra de organismos similares a rickettsia
CL2011000939A1 (es) Compuestos derivados de cefalosporinas sustituidas por un grupo catecol, con actividad antimicrobiana contra bacterias gram negativo que producen betalactamasa; composicion farmaceutica que los comprende; uso en el tratamiento de enfermedades infecciosas.
CO6751260A2 (es) Vacunas basadas en omv contra infecciones por burkholderia
GT200900230A (es) 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y uso
CA2798214C (en) Vaccine against beta-herpesvirus infection and use thereof
BRPI0807487A8 (pt) Uso de antagonistas de il-23 para o tratamento de infecção
DOP2012000299A (es) 5-fluoro-1h-pirazolopiridinas sustituidas y su uso
BR112013011263A2 (pt) "composição nematicida, e método para controlar nematódeos"
DOP2009000287A (es) Oxazolidinonas sustituidas y su uso
CL2016001524A1 (es) Derivados antibacterianos de 1h-indazol y 1h-indol.
BR112012033212A2 (pt) uso de lactobacillo inibindo a produção de gás de bactéria coliforme isolada em infantes afetados por cólica
CL2012002902A1 (es) Cepas de bacteriofagos especifica contra bacterias pertenecientes al genero vibrio para la profilaxis y terapia de vibrio anguillarum; y composicion antibacteriana que comprende dicha cepas.
UY31437A1 (es) Vacuna de mycoplasma bovis y métodos de uso de la misma
UA107204C2 (uk) Протигрибкова композиція, що містить грибковий організм pythium oligandrum
AR053775A1 (es) Nonadepsipeptidos acilados ii
MX2017009094A (es) Derivado de polimixina y usos del mismo.
CL2011001284A1 (es) Procedimiento para la produccion de vacunas contra patogenos bacterianos que producen una toxina ab; vacuna que comprende el toxoide a y/o b de clostridium; uso de dicha vacuna contra infecciones de patogenos que producen toxinas ab.
BR112012024999A2 (pt) combinação e uso
WO2011029536A3 (de) Verwendung von cyclischen ketoenolen gegen pflanzenpathogene bakterien
EP2344642B8 (en) Novel bacteriophage strains for the treatment of bacterial infections, especially drug resistant strains of the genus enterococcus
ATE524488T1 (de) Lysobactinamide
BR112022005345A2 (pt) Composições imunogênicas
MX341066B (es) Uso de una fuente de l3 y/o l5 como vacuna o como diagnostico para una enfermedad parasitaria.